Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome

David Gerber, MD, and Steven Vernino, PhD, provide a discussion on Lambert-Eaton Myasthenic Syndrome (LEMS), its association with small cell lung cancer, and the available treatment options.

EP. 1: Defining LEMS

December 21st 2021

David Gerber, MD, and Steven Vernino, MD, PhD, provide an overview of Lambert-Eaton myasthenic syndrome and its association with cancers.

EP. 2: Testing for LEMS

December 21st 2021

A neurologist explains how to test for and diagnose Lambert-Eaton myasthenic syndrome.

EP. 3: LEMS Case Review

December 28th 2021

Drs. David Gerber and Steven Vernino review the case of a 64-year-old man with Lambert-Eaton myasthenic syndrome.

EP. 4: LEMS Diagnosis: Patient Presentation and Testing

December 28th 2021

Two experts debate the preferred testing options for Lambert-Eaton myasthenic syndrome presenting with small cell lung cancer.

EP. 5: Front-line Treatment Options for SCLC

January 4th 2022

Steven Vernino, MD, describes the first-line treatment options for small cell lung cancer with Lambert-Eaton myasthenic syndrome.

EP. 6: Treatment Options for LEMS

January 4th 2022

Key opinion leaders detail the treatment options available for Lambert-Eaton myasthenic syndrome.

EP. 7: Monitoring Patients with SCLC and LEMS

January 11th 2022

Drs. Steven Vernino and David Gerber continue their conversation on their preferred treatment approaches and monitoring strategies for Lambert-Eaton myasthenic syndrome and small cell lung cancer.

EP. 8: Case Review: Small Cell Lung Cancer Following LEMS

January 11th 2022

An oncologist reviews the case of a 57-year-old man diagnosed with small cell lung cancer after Lambert-Eaton myasthenic syndrome.

EP. 9: Clinical Pearls and the Future of LEMS

January 19th 2022

Experts provide clinical pearls on treating Lambert-Eaton myasthenic syndrome and small cell lung cancer and share upcoming advances and trials they look forward to.